“CLINICAL STUDY PHASE 1/2 FOR ASSESSING THE SAFETY AND EFFECTIVENESS OF THE CELLULAR PRODUCT HC016 IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS CAUSED BY COVID-19”
Call identifier: COVID-19
Reference Nº: CO-2020/00003
Project financed by the Department of Economic Development and Infrastructures of the Basque Government.